Naomi Dempsey, MD, discussed developments in the HER2-positive breast cancer space, including personalized approaches, less ...

Cairn Surgical announces the first commercial use of its Breast Cancer Locator (BCL) System designed to improve the accuracy ...

Median overall survival of 15.6 months in Phase 2 Bria-IMT™ study patients treated in combination with immune checkpoint inhibitorOS of 15.6 ...

The FDA approval of amivantamab-vmjw (Rybrevant) in combination with chemotherapy is the first targeted treatment to cut ...

Dr. Randall A. Oyer, founding executive medical director of the 11-year-old Ann B. Barshinger Cancer Institute, is retiring.

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Data demonstrated statistically significant and clinically meaningful reduction in risk of disease progression or death with Cabometyx® ...

At the four-day-long event, representatives from pediatric cancer awareness foundations travel to Capitol Hill to speak to ...

HANSIZHUANG (serplulimab) is the world's first anti-PD-1 mAb for first-line treatment of ES-  SCLC   - HANSIZHUANG (serplulimab) is expected to become the first and only anti-PD-1 ...

Indeed, the global oncology community trusts ESMO to disseminate the latest results of cancer research. Why? Because it is ...

Ann Arbor-based Michigan Medicine will establish the Weiser Family Center for Breast Cancer after receiving a $25 million gift from the Weiser Charitable Foundation.

ANN ARBOR – C.S. Mott Children’s Hospital hosted an indoor parade through its cancer ward Tuesday in honor of National ...